Orbit Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 25-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 25-06-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 34.45 Cr
as on 25-06-2024
- Satisfied Charges ₹ 88.45 Cr
as on 25-06-2024
- Revenue 19.27%
(FY 2022)
- Profit 122.16%
(FY 2022)
- Ebitda 23.39%
(FY 2022)
- Net Worth 1.74%
(FY 2022)
- Total Assets 16.36%
(FY 2022)
About Orbit Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹34.45 Cr. The company has closed loans amounting to ₹88.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashish Sheth and Amit Sheth serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC140389
- Company No.
140389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Orbit Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Sheth  | Director | 09-May-2003 | Current |
| Ashish Sheth | Director | 09-May-2003 | Current |
Financial of Orbit Lifescience.
Orbit Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.27% increase. The company also saw a substantial improvement in profitability, with a 122.16% increase in profit. The company's net worth moved up by a moderate rise of 1.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orbit Lifescience?
In 2022, Orbit Lifescience had a promoter holding of 72.73% and a public holding of 27.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cosmetics Concept Research Private LimitedActive 8 years 10 months
Ashish Sheth and Amit Sheth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Dec 2023 | ₹1.25 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Dec 2023 | ₹1.25 Cr | Open |
Others Creation Date: 24 Jan 2022 | ₹1.38 Cr | Open |
How Many Employees Work at Orbit Lifescience?
Orbit Lifescience has a workforce of 22 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orbit Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbit Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
